Immune checkpoint blockade can synergize with radiation therapy, even in tumors resistant to checkpoint monotherapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Immune checkpoint blockade can synergize with radiation therapy, even in tumors resistant to checkpoint monotherapy ; volume:9 ; number:2 ; year:2017 ; pages:135-136 ; extent:2
EMBO molecular medicine / European Molecular Biology Organization ; 9, Heft 2 (2017), 135-136 (gesamt 2)
- Creator
- DOI
-
10.15252/emmm.201607219
- URN
-
urn:nbn:de:101:1-2022092906340350424218
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:26 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
Other Objects (12)
Immune checkpoint blockade in ovarian cancer
Smoldering myocarditis following immune checkpoint blockade
Activation of phagocytosis by immune checkpoint blockade
Evaluation of tumor-infiltrating lymphocyte dysfunction in melanoma patients resistant to immune checkpoint blockade
Checkpoint
The Role of Immune Checkpoint Blockade in Uveal Melanoma
The role of neoantigen in immune checkpoint blockade therapy
Regulatory T cells in immune checkpoint blockade antitumor therapy
Microbial biomarkers for immune checkpoint blockade therapy against cancer
Prospects for combining immune checkpoint blockade with PARP inhibition
Immune Checkpoint Blockade: The New Frontier in Cancer Treatment
Expression of Checkpoint Molecules in the Tumor Microenvironment of Intrahepatic Cholangiocarcinoma : Implications for Immune Checkpoint Blockade Therapy
Immune checkpoint blockade in ovarian cancer
Smoldering myocarditis following immune checkpoint blockade
Activation of phagocytosis by immune checkpoint blockade
Evaluation of tumor-infiltrating lymphocyte dysfunction in melanoma patients resistant to immune checkpoint blockade
Checkpoint
The Role of Immune Checkpoint Blockade in Uveal Melanoma
The role of neoantigen in immune checkpoint blockade therapy
Regulatory T cells in immune checkpoint blockade antitumor therapy
Microbial biomarkers for immune checkpoint blockade therapy against cancer
Prospects for combining immune checkpoint blockade with PARP inhibition
Immune Checkpoint Blockade: The New Frontier in Cancer Treatment
Expression of Checkpoint Molecules in the Tumor Microenvironment of Intrahepatic Cholangiocarcinoma : Implications for Immune Checkpoint Blockade Therapy
Immune checkpoint blockade in ovarian cancer
Smoldering myocarditis following immune checkpoint blockade
Activation of phagocytosis by immune checkpoint blockade
Evaluation of tumor-infiltrating lymphocyte dysfunction in melanoma patients resistant to immune checkpoint blockade
Checkpoint
The Role of Immune Checkpoint Blockade in Uveal Melanoma
The role of neoantigen in immune checkpoint blockade therapy
Regulatory T cells in immune checkpoint blockade antitumor therapy
Microbial biomarkers for immune checkpoint blockade therapy against cancer
Prospects for combining immune checkpoint blockade with PARP inhibition
Immune Checkpoint Blockade: The New Frontier in Cancer Treatment